PeopleImages/iStock via Getty Images Investment Thesis In this article, I will analyze the field of biopharma through two industry competitors: AbbVie (NYSE:ABBV, NEOE:ABBV:CA) and GSK (NYSE:GSK, OTCPK:GLAXF). I aim to illustrate the levels of their operation, which will specifically highlight AbbVie's pursuit to create medical breakthroughs and GSK's strategic abilities in the industry (and much more). We will discuss some valuation metrics to find if there is deep value in either security, too. Their  ...